HLYK - HealthLynked Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
14.76M
Enterprise Value 3
16.98M
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
5.42
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
6.24
Enterprise Value/EBITDA 6
-5.07

Trading Information

Stock Price History

Beta (3Y Monthly) 0.40
52-Week Change 3-40.21%
S&P500 52-Week Change 35.59%
52 Week High 30.4440
52 Week Low 30.0950
50-Day Moving Average 30.1411
200-Day Moving Average 30.1974

Share Statistics

Avg Vol (3 month) 3145.06k
Avg Vol (10 day) 3104.51k
Shares Outstanding 5102.48M
Float 46.66M
% Held by Insiders 160.47%
% Held by Institutions 10.11%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin -196.29%
Operating Margin (ttm)-124.50%

Management Effectiveness

Return on Assets (ttm)-122.97%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)2.72M
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)113.40%
Gross Profit (ttm)-107.58k
EBITDA -3.35M
Net Income Avi to Common (ttm)-5.34M
Diluted EPS (ttm)-0.0600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)125.74k
Total Cash Per Share (mrq)0
Total Debt (mrq)2.35M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.10
Book Value Per Share (mrq)-0.02

Cash Flow Statement

Operating Cash Flow (ttm)-2.29M
Levered Free Cash Flow (ttm)-977.2k